Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimal Invasive Treatment for Patients With Good Response to Chemoradiation With Selection and Follow-up by MRI: a Single Arm Phase-II Feasibility Study in Rectal Cancer

NCT00939666 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT00939666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00939666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimal Invasive Treatment for Patients With Good Response to Chemoradiation With Selection and Follow-up by MRI: a Single Arm Phase-II Feasibility Study in Rectal Cancer
Lead sponsor
Maastricht University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2009
Completion date
September 1, 2014
Enrollment
28 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced rectal cancer